Compare · EAR vs ELV
EAR vs ELV
Side-by-side comparison of Eargo Inc. (EAR) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EAR and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV carries a market cap of $92.84B.
- ELV has hit the wire 4 times in the past 4 weeks while EAR has been quiet.
- ELV has more recent analyst coverage (23 ratings vs 3 for EAR).
- Company
- Eargo Inc.
- Elevance Health Inc.
- Price
- -
- -
- Market cap
- -
- $92.84B
- 1M return
- -
- +0.28%
- 1Y return
- -
- +29.86%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 0
- 4
- Recent ratings
- 3
- 23
Eargo Inc.
Eargo, Inc., a medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest EAR
- SEC Form 15-12G filed by Eargo Inc.
- SEC Form S-8 POS filed by Eargo Inc.
- SEC Form S-8 POS filed by Eargo Inc.
- SEC Form S-8 POS filed by Eargo Inc.
- Brownie William returned 296 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Narula Onkarr
- Wu David James returned 25,463 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Sabet-Peyman Afshin Justin
- SEC Form 4 filed by Bayne Katie J
- SEC Form 4 filed by Spence Donald J
Latest ELV
- AM Best Assigns Indicative Issue Credit Ratings to Elevance Health, Inc.’s New Shelf Registration
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- EVP & Chief Digital Info Ofr Lavu Ratnakar sold $572,000 worth of shares (1,300 units at $440.00), decreasing direct ownership by 8% to 14,849 units (SEC Form 4)
- SEC Form S-3ASR filed by Elevance Health Inc.
- EVP & CFO Kaye Mark sold $4,658,357 worth of shares (10,584 units at $440.13) (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Names Jeff Park President of Carelon
- SEC Form 8-K filed by Elevance Health Inc.
- Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance
- The Future of Healthcare: AI-Powered, Coordinated and Proactive Care